Persistence and Adherence to GLP-1 RA treatment in Type 2 Diabetes Mellitus: a Nationwide registry study von Lassen, M C H, Johansen, N D, Modin, D, Catarig, A M, Vistisen, B K, Amadid, H, Zimmermann, E, Gislason, G, Biering-Soerensen, T

Volltext

CLINICAL OUTCOMES ASSOCIATED WITH THE USE OF ORAL SEMAGLUTIDE IN AN ADULT POPULATION WITH TYPE 2 DIABETES IN CANADA: A PROSPECTIVE REAL-WORLD STUDY (PIONEER REAL CANADA) von Reichert, S., Amadid, H., Braae, U., Bradley, R., Kim, J., Soo, V., Yale, J., Jain, A.

Volltext

CO57 Clinical and Patient-Reported Outcomes Associated With Oral Semaglutide Use in Adults With Type 2 Diabetes: A Pooled Analysis of Six Pioneer Real Prospective Real-World Studie... von Rudofsky, G, Amadid, H, Braae, UC, Catrina, SB, Mandavya, K, Kick, A, Roslind, K, Saravanan, P, van Houtum, W, Jain, A

Volltext

CLINICAL OUTCOMES ASSOCIATED WITH THE USE OF ORAL SEMAGLUTIDE IN AN ADULT POPULATION WITH TYPE 2 DIABETES IN CANADA: A PROSPECTIVE REAL-WORLD STUDY (PIONEER REAL CANADA) von Reichert, S., Amadid, H., Braae, U., Bradley, R., Kim, J., Soo, V., Yale, J., Jain, A.

Volltext

PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice von Catrina, Sergiu-Bogdan, Amadid, Hanan, Braae, Uffe C., Dereke, Jonatan, Ekberg, Neda Rajamand, Klanger, Boris, Jansson, Stefan

Volltext

Adherence to glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study von Lassen, Mats C H, Johansen, Niklas Dyrby, Modin, Daniel, Catarig, Andrei-Mircea, Vistisen, Bodil Kjeldgaard, Amadid, Hanan, Zimmermann, Esther, Gislason, Gunnar, Biering-Sørensen, Tor

Volltext